Hepatic HCV-RNA as a predictor of outcome after interferon therapy in patients with chronic hepatitis C
β Scribed by MASAAKI KONDO; KATSUAKI TANAKA; MASANORI IKEDA; SHINJU ARATA; SATORU SAITO; TAKASHI SAKAGUCHI; MANABU MORIMOTO; TAKANDO FUJII; KONOMI MITSUI; HIROSHI OKAZAKI; MASATO HOSHINO; HISAHIKO SEKIHARA
- Book ID
- 115170875
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 586 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In order to assess the efficacy of interferonβΞ± on hepatitis C viral RNA in patients with chronic hepatitis C, we analyzed the levels of HCV RNA in sera and liver tissues of 16 patients preβ and posttreatment using a semiquantitative polymerase chain reaction method. Fifteen of 16 patie
## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferonβΞ± (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes
Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-β£ (IFN-β£) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN